Item request has been placed!
×
Item request cannot be made.
×
Processing Request
[Efficacy and safety of tyrosine kinase inhibitor dasatinib plus chemotherapy in the treatment of childhood Philadelphia chromosome-positive acute lymphoblastic leukemia].
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Zhongguo dang dai er ke za zhi she Country of Publication: China NLM ID: 100909956 Publication Model: Print Cited Medium: Print ISSN: 1008-8830 (Print) Linking ISSN: 10088830 NLM ISO Abbreviation: Zhongguo Dang Dai Er Ke Za Zhi Subsets: MEDLINE
- Publication Information:
Original Publication: Changsha : Zhongguo dang dai er ke za zhi she, 1999-
- Subject Terms:
- Accession Number:
0 (Protein Kinase Inhibitors)
0 (Pyrimidines)
0 (Thiazoles)
EC 2.7.10.1 (Protein-Tyrosine Kinases)
RBZ1571X5H (Dasatinib)
- Publication Date:
Date Created: 20150626 Date Completed: 20150930 Latest Revision: 20151119
- Publication Date:
20240829
- Accession Number:
26108329
No Comments.